Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 234

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Association Between Titin Loss-of-Function Variants and Early-Onset Atrial Fibrillation

Open access
Choi, Seung Hoan, Weng, Lu-Chen, Roselli, Carolina, Lin, Honghuang, Haggerty, Christopher M., Shoemaker, M. Benjamin, Barnard, John, Arking, Dan E., Chasman, Daniel I., Albert, Christine M., Chaffin, Mark, Tucker, Nathan R., Smith, Jonathan D., Gupta, Namrata, Gabriel, Stacey, Margolin, Lauren, Shea, Marisa A., Shaffer, Christian M., Yoneda, Zachary T., Boerwinkle, Eric, Smith, Nicholas L., Silverman, Edwin K., Redline, Susan, Vasan, Ramachandran S., Burchard, Esteban G., Gogarten, Stephanie M., Laurie, Cecelia, Blackwell, Thomas W., Abecasis, Gonçalo, Carey, David J., Fornwalt, Brandon K., Smelser, Diane T., Baras, Aris, Dewey, Frederick E., Jaquish, Cashell E., Papanicolaou, George J., Sotoodehnia, Nona, Van Wagoner, David R., Psaty, Bruce M., Kathiresan, Sekar, Darbar, Dawood, Alonso, Alvaro, Heckbert, Susan R., Chung, Mina K., Roden, Dan M., Benjamin, Emelia J., Murray, Michael F., Lunetta, Kathryn L., Lubitz, Steven A., Ellinor, Patrick T., For the DiscovEHR study and the NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium·2018·JAMA

Abstract

Importance: Atrial fibrillation (AF) is the most common arrhythmia affecting 1% of the population. Young individuals with AF have a strong genetic association with the disease, but the mechanisms remain incompletely understood. Objective: To perform large-scale whole-genome sequencing to identify genetic variants related to AF. Design, Setting, and Participants: The National Heart, Lung, and Blood Institute's Trans-Omics for Precision Medicine Program includes longitudinal and cohort studies that underwent high-depth whole-genome sequencing between 2014 and 2017 in 18 526 individuals from the United States, Mexico, Puerto Rico, Costa Rica, Barbados, and Samoa. This case-control study included 2781 patients with early-onset AF from 9 studies and identified 4959 controls of European ancestry from the remaining participants. Results were replicated in the UK Biobank (346 546 participants) and the MyCode Study (42 782 participants). Exposures: Loss-of-function (LOF) variants in genes at AF loci and common genetic variation across the whole genome. Main Outcomes and Measures: Early-onset AF (defined as AF onset in persons <66 years of age). Due to multiple testing, the significance threshold for the rare variant analysis was P = 4.55 × 10-3. Results: Among 2781 participants with early-onset AF (the case group), 72.1% were men, and the mean (SD) age of AF onset was 48.7 (10.2) years. Participants underwent whole-genome sequencing at a mean depth of 37.8 fold and mean genome coverage of 99.1%. At least 1 LOF variant in TTN, the gene encoding the sarcomeric protein titin, was present in 2.1% of case participants compared with 1.1% in control participants (odds ratio [OR], 1.76 [95% CI, 1.04-2.97]). The proportion of individuals with early-onset AF who carried a LOF variant in TTN increased with an earlier age of AF onset (P value for trend, 4.92 × 10-4), and 6.5% of individuals with AF onset prior to age 30 carried a TTN LOF variant (OR, 5.94 [95% CI, 2.64-13.35]; P = 1.65 × 10-5). The association between TTN LOF variants and AF was replicated in an independent study of 1582 patients with early-onset AF (cases) and 41 200 control participants (OR, 2.16 [95% CI, 1.19-3.92]; P = .01). Conclusions and Relevance: In a case-control study, there was a statistically significant association between an LOF variant in the TTN gene and early-onset AF, with the variant present in a small percentage of participants with early-onset AF (the case group). Further research is necessary to understand whether this is a causal relationship.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.2018.18179

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 234

Metadata

Authors
Choi, S. H., Weng, L.-C., Roselli, C., Lin, H., Haggerty, C. M., Shoemaker, M. B., Barnard, J., Arking, D. E., Chasman, D. I., Albert, C. M., Chaffin, M., Tucker, N. R., Smith, J. D., Gupta, N., Gabriel, S., Margolin, L., Shea, M. A., Shaffer, C. M., Yoneda, Z. T., Boerwinkle, E., Smith, N. L., Silverman, E. K., Redline, S., Vasan, R. S., Burchard, E. G., Gogarten, S. M., Laurie, C., Blackwell, T. W., Abecasis, G., Carey, D. J., Fornwalt, B. K., Smelser, D. T., Baras, A., Dewey, F. E., Jaquish, C. E., Papanicolaou, G. J., Sotoodehnia, N., Van Wagoner, D. R., Psaty, B. M., Kathiresan, S., Darbar, D., Alonso, A., Heckbert, S. R., Chung, M. K., Roden, D. M., Benjamin, E. J., Murray, M. F., Lunetta, K. L., Lubitz, S. A., Ellinor, P. T., & For the DiscovEHR study and the NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium
Venue
JAMA
Published
2018-12-11
Volume
320
Issue
22
Pages
2354
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W2903835113
Cited by
234
References
12
FWCI
12.21
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association Between Titin Loss-of-Function Variants and Early-Onset Atrial Fibrillation. https://app.cochat.ai/papers/10.1001/jama.2018.18179
The paper
Choi, S. H., Weng, L.-C., Roselli, C., Lin, H., Haggerty, C. M., Shoemaker, M. B., Barnard, J., Arking, D. E., Chasman, D. I., Albert, C. M., Chaffin, M., Tucker, N. R., Smith, J. D., Gupta, N., Gabriel, S., Margolin, L., Shea, M. A., Shaffer, C. M., Yoneda, Z. T., . . . For the DiscovEHR study and the NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium. (2018). Association Between Titin Loss-of-Function Variants and Early-Onset Atrial Fibrillation. JAMA. https://doi.org/10.1001/jama.2018.18179

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.